We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601211:SSEGuotai Haitong Securities Co., Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥17.94

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guotai Haitong Securities is trading at CNY 17.94, barely above its technical support of CNY 17.87. The stock’s 20‑day SMA (18.98) lies just above the current price, indicating short‑term weakness. A low RSI of 27.2 signals that the shares are oversold, while the MACD remains bearish. Volatility over the past 30 days is moderate at 18 % and the beta of 0.21 points to minimal market‑wide swings. Fundamentally, the company posts a trailing PE of 9.86 versus an industry average of 16.35, suggesting a sizable valuation gap. Dividend yield stands at 2.4 % with a payout ratio under 25 %, supporting income appeal.
However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio near 276 %, which could constrain flexibility. Cash generation remains solid, reflected by operating cash flow of CNY 52.8 bn and a ROE of 10.4 %. The DCF model values the firm at roughly CNY 91, far above the market price, reinforcing an undervalued narrative. The company’s recent rebranding in April 2025 signals a strategic push to capture broader market share. Given the stable trading volume and low liquidity risk, the shares can be entered without significant execution concerns. Overall, the combination of deep discount, sustainable dividend, and limited price volatility makes the stock attractive for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • oversold RSI indicating potential bounce
  • bearish MACD confirming short‑term downtrend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant PE discount to industry peers
  • 2.4% dividend yield with low payout ratio
  • DCF fair value far above market price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustainable dividend supported by strong cash flow
  • strategic position in China’s capital markets
  • potential sector recovery offsetting high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth128.20%
Profit Margin40.27%
P/E Ratio9.9
ROE10.43%
ROA1.81%
Debt/Equity275.98
P/B Ratio1.0
Op. Cash FlowCN¥52.8B
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI27.2
SupportCN¥17.87
ResistanceCN¥20.25
MA 20CN¥18.98
MA 50CN¥19.87
MA 200CN¥19.53
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueCN¥91.42
GradeUndervalued
TypeValue
Dividend Yield2.40%

Risk Assessment

Beta0.21
Volatility18.01%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.